Bioequivalence determination of topical ketoprofen using a dermatopharmacokinetic approach and excised skin penetration

International Journal of Pharmaceutics

Volumn 284, Issue 1-2, 2004, Pages 23-30

  Lodén, Marie ^a,c   Åkerström, Ulf ^a   Lindahl, Karin ^a,b   Berne, Berit ^b  

^a Box 622   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bioavailability; Dermatopharmacokinetic; Ketoprofen

Indexed keywords

ALCOHOL; KETOPROFEN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; FEMALE; GEL; HUMAN; HUMAN TISSUE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SKIN PENETRATION; STATISTICAL SIGNIFICANCE; STRATUM CORNEUM; THERMODYNAMICS;

ADMINISTRATION, TOPICAL; ADULT; FEMALE; HUMANS; KETOPROFEN; MALE; SKIN ABSORPTION; THERAPEUTIC EQUIVALENCY;

EID: 5344238200     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.07.018     Document Type: Article

References (26)

1. H. Bagheri, V. Lhiaubet, J.L. Montastruc, and N. Chouini-Lalanne Photosensitivity to ketoprofen: mechanisms and pharmacoepidemiological data Drug Saf. 22 2000 339 349
2. S. Baudot, B. Milpied, and C. Larousse Cutaneous side effects of ketoprofen gels: results of a study based on 337 cases Therapie 53 1998 137 144
3. F.P. Bonina, C. Puglia, T. Barbuzzi, P. de Caprariis, F. Palagiano, M.G. Rimoli, and A. Saija In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenac Eur. J. Pharm. Sci. 14 2001 123 134
4. G.C. Ceschel, P. Maffei, and S. Lombardi Borgia Correlation between the transdermal permeation of ketoprofen and its solubility in mixtures of a pH 6.5 phosphate buffer and various solvents Drug Deliv. 9 2002 39 45
5. EMEA, 2001. Note for guidance on the investigation of bioavailability and bioequivalence. CPMP/EWP/QWP/1401/98.
6. J.W. Gould, M.G. Mercurio, and C.A. Elmets Cutaneous photosensitivity diseases induced by exogenous agents J. Am. Acad. Dermatol. 33 1995 551 573
7. J. Hadgraft, M. Whitefield, and P.H. Rosher Skin penetration of topical formulations of ibuprofen 5%: an in vitro comparative study Skin Pharmacol. Appl. Skin Physiol. 16 2003 137 142
8. D. Howes, R. Guy, J. Hadgraft, J. Heylings, U. Hoeck, F. Kemper, H. Maibach, J.P. Marty, H. Merk, J. Parra, D. Rekkas, I. Rondelli, H. Schaefer, U. Täuber, and N. Verbiese Methods for assessing percutaneous absorption. The report and recommendations of ECVAM workshop 13 ATLA 24 1996 81 106
9. R. Johnson, B.P. Nusbaum, S.N. Horwitz, and P. Frost Transfer of topically applied tetracycline in various vehicles Arch. Dermatol. 119 1983 660 663
10. T.G. Kantor Ketoprofen: a review of its pharmacologic and clinical properties Pharmacotherapy 6 1986 93 103
11. J. Lademann, H. Weigmann, C. Rickmeyer, H. Barthelmes, H. Schaefer, G. Mueller, and W. Sterry Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice Skin Pharmacol. Appl. Skin Physiol. 12 1999 247 256
12. M. Loden The in vitro hydrolysis of diisopropyl fluorophosphate during penetration through human full-thickness skin and isolated epidermis J. Invest. Dermatol. 85 1985 335 339
13. 2 with growth hormone releasing activity penetrates human epidermis in vitro Acta Pharm. Suec. 25 1988 27 30
14. Lodén, M., Åkerström, U., Lindahl, K., Berne, B., 2004. The effect of titanium dioxide on the photostability of ketoprofen, submitted for publication.
15. R.A. Moore, M.R. Tramer, D. Carroll, P.J. Wiffen, and H.J. McQuay Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs Br. Med. J. 316 1998 333 338
16. D. Paolino, C.A. Ventura, S. Nistico, G. Puglisi, and M. Fresta Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability Int. J. Pharm. 244 2002 21 31
17. L.K. Pershing, J.L. Nelson, J.L. Corlett, S.P. Shrivastava, D.B. Hare, and V.P. Shah Assessment of dermatopharmacokinetic approach in the bioequivalence determination of topical tretinoin gel products J. Am. Acad. Dermatol. 48 2003 740 751
18. Y.-S. Rhee, J.-G. Choi, E.-S. Park, and S.-C. Chi Transdermal delivery of ketoprofen using microemulsions Int. J. Pharm. 228 2001 161 170
19. L.E. Rhodes, and B.L. Diffey Fluorescence spectroscopy: a rapid, noninvasive method for measurement of skin surface thickness of topical agents Br. J. Dermatol. 136 1997 12 17
20. SADRAC, 1998. Ketoprofen gel contact dermatitis and photosensitivity. Bulletin of the Swedish Adverse Drug Reactions Advisory Committee (SADRAC).
21. SCCNFP, 2000. Opinion concerning titanium dioxide, Colipa no. S75 adopted by the SCCNFP during the 14th Plenary Meeting. Scientific Committee on Cosmetic Products and Non-food Products Intended for Consumers, October 24. http://europa.eu.int/comm/food/fs/sc/sccp/out135_en.html.
22. A.K. Shah, G. Wei, R.C. Lanman, V.O. Bhargava, and S.J. Weir Percutaneous absorption of ketoprofen from different anatomical sites in man Pharm. Res. 13 1996 168 172
23. V.P. Shah, G.L. Flynn, A. Yacobi, H.I. Maibach, C. Bon, N.M. Fleischer, T.J. Franz, S.A.J.K. Kaplan, L.J. Lesko, J.P. Marty, L.K. Pershing, H. Schaefer, J.A. Sequeira, S.P. Shrivastava, J. Wilkin, and R.L. Williams Bioequivalence of topical dermatological dosage forms - methods of evaluation of bioequivalence Pharm. Res. 15 1998 167 171
24. S.K. Singh, D.S. Roane, I.K. Reddy, M.J. Durrani, and M.A. Khan Effect of additives on the diffusion of ketoprofen through human skin Drug Develop. Ind. Pharm. 22 1996 471 474
25. J.P. Skelly, V.P. Shah, H.I. Maibach, R.H. Guy, R.C. Wester, G. Flynn, and A. Yacobi FDA and AAPS report of the workshop on principles and practices of in vitro percutaneous penetration studies: relevance to bioavailability and bioequivalence Pharm. Res. 4 1987 265 267
26. E.M. Veys 20 years' experience with ketoprofen Scand. J. Rheumatol. Suppl. 90 1991 1 44